Literature DB >> 32251738

Predictor variables in the success of slow-release dinoprostone used for cervical ripening in intrauterine growth restriction pregnancies.

Süleyman Cemil Oğlak1, Muhammed Hanifi Bademkıran2, Mehmet Obut2.   

Abstract

OBJECTIVE: This study aims to evaluate the consequences of a trigger by vaginal Dinoprotone on outcome of pregnancies with Intrauterine growth restriction (IUGR).
MATERIALS AND METHODS: This retrospective study included 161 induced IUGR fetuses (35-39 weeks). Consecutive patients who were evaluated formed the basis of the clinical outcomes. The penalized maximum likelihood estimation (PMLE) method was used instead of traditional logistic regression in order to reduce the risk of overfitting.
RESULTS: Of the 25,678 deliveries that occurred during the study period, 161 (0.6%) women underwent IUGR delivery; of these, 117 (73%) succeeded and 44 (27%) failed to achieve cervical ripening using the dinoprostone slow-release vaginal insert. Two predictors were associated with dinoprostone vaginal delivery success: Parity (OR:1.4([0.89-2.3]), and Bishop score (OR:1.54[1.23-1.94]). The PMLE model correctly classified 78% participants (c-index: 0.78).
CONCLUSION: Basic parameters such as parity and Bishop score can be used to predict successful vaginal birth following dinoprostone slow-release vaginal insert administration.
Copyright © 2020 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Dinoprostone; IUGR; Induction of labor

Mesh:

Substances:

Year:  2020        PMID: 32251738     DOI: 10.1016/j.jogoh.2020.101739

Source DB:  PubMed          Journal:  J Gynecol Obstet Hum Reprod        ISSN: 2468-7847


  9 in total

1.  Comparison of the Dinoprostone Vaginal Insert and Dinoprostone Tablet for the Induction of Labor in Primipara: A Retrospective Cohort Study.

Authors:  Ning-Shiuan Ting; Dah-Ching Ding; Yu-Chi Wei
Journal:  J Clin Med       Date:  2022-06-19       Impact factor: 4.964

2.  A new and more effective feticide technique in late termination of pregnancy: potassium chloride injection into the interventricular septum of the fetal heart.

Authors:  Sema Süzen Çaypınar; Süleyman Cemil Oğlak; İbrahim Polat; Kübra Kurt Bilirer; Salim Sezer; Zeynep Gedik Özköse; Sema Karakaş
Journal:  Arch Gynecol Obstet       Date:  2022-10-21       Impact factor: 2.493

3.  Prenatal diagnosis and genetic counseling of a uniparental isodisomy of chromosome 8 with no phenotypic abnormalities.

Authors:  Chunjiao Yu; Ying Tian; Liang Qi; Bo Wang
Journal:  Mol Cytogenet       Date:  2022-04-26       Impact factor: 1.904

4.  Evaluation of Antepartum Factors for Predicting the Risk of Emergency Cesarean Delivery in Pregnancies Complicated With Placenta Previa.

Authors:  Süleyman Cemil Oğlak; Fatma Ölmez; Şeyhmus Tunç
Journal:  Ochsner J       Date:  2022

5.  Prenatal diagnosis and genetic counseling of a 10p11.23q11.21 duplication associated with normal phenotype.

Authors:  Jieping Song; Wei Jiang; Chengcheng Zhang; Bo Wang
Journal:  Mol Cytogenet       Date:  2022-06-03       Impact factor: 1.904

6.  A novel marker endoplasmic reticulum to nucleus signalling-1 in the diagnosis of gestational diabetes mellitus

Authors:  Sema Süzen Çaypınar; Mustafa Behram
Journal:  J Turk Ger Gynecol Assoc       Date:  2022-06-01

7.  Association of Maternal Serum Uric Acid and Cystatin C Levels in Late Pregnancy with Adverse Birth Outcomes: An Observational Cohort Study in China.

Authors:  Xiaosong Yuan; Xiaoya Han; Chenbo Jia; Huiyan Wang; Bin Yu
Journal:  Int J Womens Health       Date:  2022-02-17

8.  First Trimester Mean Platelet Volume, Neutrophil to Lymphocyte Ratio, and Platelet to Lymphocyte Ratio Values Are Useful Markers for Predicting Preeclampsia.

Authors:  Süleyman Cemil Oğlak; Şeyhmus Tunç; Fatma Ölmez
Journal:  Ochsner J       Date:  2021

9.  The association between protein levels in 24-hour urine samples and maternal and neonatal outcomes of pregnant women with preeclampsia.

Authors:  Gülşah Aynaoğlu Yıldız; Emsal Pınar Topdağı Yılmaz
Journal:  J Turk Ger Gynecol Assoc       Date:  2022-09-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.